Updated 8 Sept 2026 · Sanctions lists stale 71d

FRSociété par actions simplifiée (SAS)

COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE

  • StatusActive & verified
  • Registered officeNormandie
Overall verdict CLEAR

Clear to engage — no blocking risk signals on record.

  • Sanctions: clear
  • Court: clear
  • Compliance: Standard
  • Credit: A+
  • Financials 8.07 B € · FY 2024
  • Public contracts 1 contract · 3.99 M €
  • NIS2 scope Out of scope
IČO
493265284
DIČ
VAT ID
FR45493265284
LEI
969500OCNBKOCW914A11
NACE
4646 · Wholesale and retail trade; repair of motor vehicles

Compliance verdictRECOMMENDATION

Standard

All risk checks clear. Standard onboarding flow.

Why? No risk signals raised.

See full breakdown →

Credit standingA+ · 100/100

A+
100/100

Better than 92.1 % of france companies

Percentile vs FRANCE peers

Top-tier creditworthiness · very low 12-month default risk.

NIS2 directiveOUT OF SCOPE

Out of scope

Not regulated by NIS2 directive.

Scope details →

Jump to section

Business

Financials FY 2024

Revenue
2016: 3.50 B €€3500M20162017: 3.55 B €€3547M20172018: 3.76 B €€3757M20182020: 3.95 B €€3947M20202021: 4.30 B €€4298M20212024: 8.07 B €€8072M2024
Net profit
2016: 19.83 M €€20M20162017: 18.59 M €€19M20172018: 19.88 M €€20M20182020: 18.25 M €€18M20202021: 27.78 M €€28M20212024: 36.75 M €€37M2024
Year
Revenue
8.07 B €
Net profit
36.75 M €
EBITDA
Assets
1.85 B €
Equity
589.76 M €
Margin
0.5 %

Revenue

8.07 B €

+88% YoY 3726.1× median

Net profit

36.75 M €

+32% YoY 884.0× median

EBITDA

Total assets

1.85 B €

+60% YoY 1409.0× median

Total equity

589.76 M €

+94% YoY 1661.7× median

Net assets

589.76 M €

+94% YoY 1021.4× median

Debt/equity

ROA

ROE

Profit margin

0.5 %

-30% YoY 0.2× median

Asset turnover

4.36×

+17% YoY 2.6× median

Current ratio

Business

Public contracts

  • 1 Contracts
  • 3.99 M € Total value
  • 100 % Top buyer share
  • Last 12 months · 0
3.99 M € 20192020202120222023202420252026 2019: 0 € · 0 contracts2020: 0 € · 0 contracts2021: 0 € · 0 contracts2022: 0 € · 0 contracts2023: 0 € · 0 contracts2024: 3.99 M € · 1 contracts2025: 0 € · 0 contracts2026: 0 € · 0 contracts

Risk profile

Compliance signals

Refreshed 29 Jun 2026 · behind schedule

10 signals checked 10 clear 0 soft 0 fail
  • SanctionsOFAC + EU + UN + UK HMT watchlistsClear
  • ÚVO debarmentPublic-procurement debarment list (SK)N/A · non-SK
  • Criminal convictionConvicted legal-entities register (GP SR, z.91/2016)N/A · non-SK
  • BankruptcyActive bankruptcy proceedingsNone
  • LiquidationVoluntary liquidation in progressNone
  • RestructuringCourt-supervised restructuringNone
  • Tax debtTax authority debt registryN/A · non-SK
  • Social-ins. debtSociálna poisťovňa debt registryN/A · non-SK
  • Health-ins. debtVšZP + Dôvera + Union debt registersN/A · non-SK
  • Shared-address concentrationFirms sharing the same registered officeNone

Risk profile

Credit score factors

Public-register delinquency index

A 100/100

Public-register delinquency (not trade DBT)

No negative public records on file

10 factors

Factor Weight Evidence
Liquidity 0 Bez dát likvidity / Liquidity data not collected
Solvency 0 Bez VZaS dát / No statements
Profitability +18 Kladný zisk €36,748,596 · Tržby ≥ €10M
Payment hygiene 0 Žiadne dlhy / No outstanding debts
Filing discipline 0 Aktívne podávanie / Active filings
Stability 5y +8 Firma existuje 19 rokov
Sector outlook 0 Sektorový výhľad neutrálny / Neutral sector outlook
Counterparty mix +4 1 verejných kontraktov
Court-case trend 0 Bez kartelových/sankčných konaní / No cartel/sanctions cases
Size & scale 0 Veľkostné dáta chýbajú / Size data missing

Risk profile

Sanctions & watchlist screening

Refreshed 29 Jun 2026 · behind schedule

Direct entity

Clear

COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUE — no match on any list

UBO / ownership chain

Clear

No PEP linkage in ownership chain

Statutory bodies

Clear

All statutory members screened against 4 lists

Cross-referenced against 4 consolidated watchlists

Each feed refreshes independently — staleness flagged in red.
Watchlist Jurisdiction Records Last refresh Direct UBO chain Person
OFAC SDN ListUS Treasury Specially Designated Nationals US 19,717 71d ago ✓ Clear ✓ Clear ✓ Clear
EU Consolidated ListCouncil Regulation sanctions register EU 6,234 71d ago ✓ Clear ✓ Clear ✓ Clear
UN Security CouncilConsolidated UN sanctions list UN 1,011 71d ago ✓ Clear ✓ Clear ✓ Clear
UK HMT ConsolidatedUK Treasury sanctions list UK 5,120 71d ago ✓ Clear ✓ Clear ✓ Clear

Risk profile

NIS2 cybersecurity scope

Refreshed 8 Sept 2026

Out of scope Entity class

Not in scope of NIS2 Directive based on NACE classification and size thresholds.

Network

People & ownership

Directeur général délégué (70)
Jean Daniel BREVILLIERS
Directeur Général (53)
Marc Marcel HOESCHEN
Président de SAS (73)
OLIVIER BRONCHAIN
Commissaire aux comptes titulaire (71)
PRICEWATERHOUSECOOPERS AUDIT
Commissaire aux comptes titulaire (71)
RSM PARIS

Network

Statutory history

No statutory history on file.

Country source does not expose role timelines for this entity.

Reference

Registers

Legal name
COMPAGNIE D'EXPLOITATION ET DE REPARTITION PHARMACEUTIQUEINPI RNE
Legal form
Société par actions simplifiée (SAS)INPI RNE
Registered office
NormandieINPI RNE
Court register
Incorporated
4 Dec 2006 · 20yINPI RNE
Share capital
IČO
493265284INPI RNE
DIČ
VAT ID (IČ DPH)
FR45493265284 · activeFS
LEI
969500OCNBKOCW914A11GLEIF
EORI
EUID
Primary activity (NACE)
4646 · Wholesale and retail trade; repair of motor vehiclesRPO/ŠÚSR

Registered office

Normandie

  • 0 No other companies on this address
  • 2006 Address on file since 2006

No map coordinates on file yet.

Find address on the map →

Reference

Sources

RPO — Register právnických osôb 6 fields · — (no timestamp)

Slovak business register: IČO, legal form, registered office, statutory body.

data.gov.sk
Cadence
weekly
License
CC-BY 4.0
Snapshot age
Hash

Surfaced fields

iconamelegal_formaddressestablished_onstatutary
RUZ — Register účtovných závierok 6 fields · 1d (fresh · 1d)

Annual audited financial filings 2013–latest, machine-readable.

registeruz.sk
Cadence
weekly
License
Public domain (state)
Snapshot age
1d
Hash

Surfaced fields

financial_yearturnoverprofitebitdatotal_assetsequity
FS — Finančná správa 5 fields · 1d (fresh · 1d)

Tax IDs, VAT status, tax-debt + payroll-arrears lists.

financnasprava.sk
Cadence
weekly
License
Public sector info (zákon 211/2000)
Snapshot age
1d
Hash

Surfaced fields

dicic_dphis_vat_payerhas_tax_debttax_reliability
OV — Obchodný vestník 4 fields · 1d (fresh · 1d)

Commercial bulletin filings, share-capital + statutory changes.

justice.gov.sk
Cadence
daily
License
Public sector info
Snapshot age
1d
Hash

Surfaced fields

event_typedescriptionpublished_atissue_no
CRZ — Centrálny register zmlúv 5 fields · 1d (fresh · 1d)

Public-sector contracts where company is supplier or buyer.

crz.gov.sk
Cadence
weekly
License
CC-0
Snapshot age
1d
Hash

Surfaced fields

supplier_cinauthoritysubjectsigned_onamount
Sankčné zoznamy 4 fields · 71d (stale · 71d)

EU, OFAC, UN, UK

EÚ/OFAC/UN/UK
Cadence
daily
License
Public issuing authorities: OFAC (public domain), EU FSF (Commission Decision 2011/833/EU), UN, UK (OGL v3.0)
Snapshot age
71d
Hash

Surfaced fields

is_sanctionedsanctions_targetslist_sourceadded_on
GLEIF — Global LEI Foundation 3 fields · — (no timestamp)

Legal Entity Identifier registry, ISIN + LEI cross-ref.

gleif.org
Cadence
daily
License
CC0
Snapshot age
Hash

Surfaced fields

leiparent_leiregistration_status
Entyrix Credit Scoring 3 fields · 1d (fresh · 1d)

Proprietary credit score — 10 factors, A+ to E grades.

Entyrix
Cadence
weekly
License
Proprietary
Snapshot age
1d
Hash

Surfaced fields

credit_scorecredit_gradecredit_computed_at
NIS2 scoping 3 fields · 0d (fresh · 0d)

Auto-derived scope (Annex I+II × size × turnover).

Entyrix
Cadence
monthly
License
Act 366/2024 — public
Snapshot age
0d
Hash

Surfaced fields

nis2_in_scopenis2_categorynis2_sector

Reference

API access

GET /api/v1/companies/493265284/full
# Full company graph — 14 sections (~30 kB JSON, p95 89ms)
curl -H "Authorization: Bearer sk_live_…" \
     -H "Accept: application/json" \
     "https://entyrix.com/api/v1/companies/493265284/full"

# {
#   "ico":        "493265284",
#   "compliance": { "tier": "STANDARD", "signals": [ ... ] },
#   "credit":     { "grade": "A+", "score": 100 },
#   "nis2":       { "scope": null },
#   "financials": [ ... ], "officers": [ ... ], "ubo": [ ... ], "contracts": { ... }
# }

All endpoints take a Bearer token. Free tier: 100 req/day. Paid tiers: 600 req/min.

Get notified when this company changes

Statutory bodies, sanctions, financials, compliance flags — one email when anything shifts. Free during beta. Double-opt-in confirmation; unsubscribe any time.

Email used only for change notifications · GDPR Art. 6(1)(a) consent